Want to join the conversation?
$HRL 3Q15 Q&A: Aslam of Stephens asked about reasons for being positive in China business. Jeffrey replied, this year, it’s going to be a double digit returning entity. At macro level things going on with their currency, stock market and so forth, we really have not seen any detrimental impact to our sales capabilities or margins on that business.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.